| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 653624 | Null | 0.00313644776247642 | 0.25069487 |
| NSC 684836 | Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- | 0.00313644776247642 | 0.025990337 |
| NSC 711745 | Null | 0.00313644776247642 | 0.204481 |
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.00313644776247642 | 0.26474979 |
| NSC 726262 | 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one | 0.00313644776247642 | 0.095638942 |
| NSC 736164 | pyrazoline derivative | 0.00313644776247642 | 0.3108779 |
| NSC 526333 | 2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime | 0.00356954838698631 | 0.18450889 |
| NSC 618636 | Null | 0.00356954838698631 | 0.16300545 |
| NSC 646233 | Null | 0.00356954838698631 | 0.03844741 |
| NSC 702106 | Null | 0.00356954838698631 | -0.009320463 |